Clinical trial

Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural…

NCT00114205 · University of Virginia, Other · Completed

Key facts

NCT number NCT00114205
Title Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion
Official title Phase I Trial of Intrapleural Docetaxel Administered Via an Implantable Catheter in Subjects With a Malignant Pleural Effusion
Lead sponsor University of Virginia, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Metastatic Cancer
Intervention type Drug, Procedure
Interventions docetaxel, therapeutic thoracoscopy
Enrollment 24
Start date Jul 1, 2003
First posted Jun 14, 2005
Last update posted Mar 18, 2010
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies